Nabriva: Meitheal Pharmaceuticals acquires Contepo from Nabriva Therapeutics
Contepo is a novel, intravenous, broad spectrum antibiotic with demonstrated activity against most multi-drug resistant strains that cause complicated urinary tract infections.
Read full article »
Nabriva Therapeutics operates as a biopharmaceutical company, discovers and develops of antibiotics.
Read more